1. Retinol-binding protein type 1 expression predicts poor prognosis in head and neck squamous cell carcinoma.
- Author
-
Fu LL, Yan M, Yu X, Shao M, Gosau M, Friedrich RE, Vollkommer T, Smeets R, Feng HC, and Xu L
- Subjects
- Humans, Prognosis, Male, Female, Middle Aged, Gene Expression Regulation, Neoplastic, Retinol-Binding Proteins, Plasma genetics, Retinol-Binding Proteins, Plasma metabolism, Nomograms, Aged, RNA, Messenger genetics, RNA, Messenger metabolism, Retinol-Binding Proteins, Cellular, Squamous Cell Carcinoma of Head and Neck genetics, Squamous Cell Carcinoma of Head and Neck mortality, Squamous Cell Carcinoma of Head and Neck metabolism, Squamous Cell Carcinoma of Head and Neck pathology, Head and Neck Neoplasms genetics, Head and Neck Neoplasms metabolism, Head and Neck Neoplasms mortality, Head and Neck Neoplasms pathology, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, DNA Methylation
- Abstract
Background: Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent malignancy worldwide, with high incidence and poor survival rates. RBP1 is highly expressed in several kinds of cancer and plays a potential prognostic factor. However, the relationship between RBP1 and HNSCC were analyzed based on The Cancer Genome Atlas (TCGA) database., Materials and Methods: RBP1 expression and clinical information were obtained from the Cancer Genome Atlas (TCGA) database. Tumor tissue and adjacent normal tissue of 6 HNSCC patients were collected to analyze the RBP1 mRNA expression level by quantitative PCR. Cox regression analysis was used to evaluate the prognostic values of RBP1 and clinical data in HNSCC. A nomogram was also established to predict the impact of RBP1 on prognosis based on Cox multivariate results. The methylation level of RBP1 in HNSC and its prognosis were analyzed in UALACN and MethSurv. Finally, the potential biological functions of RBP1 were investigated using gene set enrichment analysis (GSEA) and single sample GSEA (ssGSEA)., Results: The mRNA expression levels of RBP1 were highly expressed in HNSCC tissue. The Cox analyses demonstrate that highly-expressed RBP1 is an independent prognosis marker(P < 0.05). ROC curve analysis showed that performances of RBP1 (area under the ROC curve: 0.887, sensitivity: 84.1%, specificity: 79.9%). The methylation was increased in HNSCC patients compared with normal subjects(P < 0.05) and was associated with better prognosis at sites cg06208339, cg12298268, cg12497564, cg15288618, cg20532370, cg23448348. Additionally, RBP1 expression is mildly associated with immune cell infiltration and immunological checkpoints., Conclusion: RBP1 is overexpressed and associated with poor patient prognosis in head and neck squamous cell carcinoma., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF